Literature DB >> 16772729

Interleukin 25 in allergic airway inflammation.

Tomohiro Tamachi1, Yuko Maezawa, Kei Ikeda, Itsuo Iwamoto, Hiroshi Nakajima.   

Abstract

T helper 2 (Th2) cells induce allergic inflammation through the production of cytokines such as interleukin (IL)-4, IL-5 and IL-13. Recently, it has been demonstrated that a novel IL-17 family cytokine IL-25 (IL-17E) is a product of activated Th2 cells and mast cells. Interestingly, when systemically administered to mice, IL-25 induces IL-4, IL-5 and IL-13 production from undefined non-T/non-B cells and then induces Th2-type immune responses such as blood eosinophilia and increased serum immunoglobulin E levels. In addition, we have recently shown that IL-25 mRNA is expressed in the lung after an inhaled antigen challenge in sensitized mice and that neutralization of the produced IL-25 by soluble IL-25 receptor decreases antigen-induced eosinophil and CD4+ T cell recruitment into the airways. Moreover, we have shown that the enforced expression of IL-25 in the lung significantly enhances antigen-induced Th2 cytokine production and eosinophil recruitment into the airways, and that the IL-25-mediated enhancement of antigen-induced eosinophil recruitment is inhibited by the depletion of CD4+ T cells. Thus, it is suggested that IL-25 plays an important role in enhancing allergic airway inflammation by a CD4+ T-cell-dependent mechanism. Copyright 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16772729     DOI: 10.1159/000092713

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  9 in total

1.  Mucus secretion by single tracheal submucosal glands from normal and cystic fibrosis transmembrane conductance regulator knockout mice.

Authors:  Juan P Ianowski; Jae Young Choi; Jeffrey J Wine; John W Hanrahan
Journal:  J Physiol       Date:  2007-01-04       Impact factor: 5.182

Review 2.  Is there a future for biologics in the management of chronic rhinosinusitis?

Authors:  Kent Lam; Robert C Kern; Amber Luong
Journal:  Int Forum Allergy Rhinol       Date:  2016-04-22       Impact factor: 3.858

3.  IL-17RB+ granulocytes are associated with airflow obstruction in asthma.

Authors:  Lin Li; Nicholas W Lukacs; Matthew A Schaller; Bryan Petersen; Alan P Baptist
Journal:  Ann Allergy Asthma Immunol       Date:  2016-12       Impact factor: 6.347

4.  Interleukin-25 fails to activate STAT6 and induce alternatively activated macrophages.

Authors:  Carmine Stolfi; Roberta Caruso; Eleonora Franzè; Massimiliano Sarra; Daniela De Nitto; Angelamaria Rizzo; Francesco Pallone; Giovanni Monteleone
Journal:  Immunology       Date:  2010-09-14       Impact factor: 7.397

5.  Interleukin-17 drives pulmonary eosinophilia following repeated exposure to Aspergillus fumigatus conidia.

Authors:  Benjamin J Murdock; Nicole R Falkowski; Andrew B Shreiner; Amir A Sadighi Akha; Roderick A McDonald; Eric S White; Galen B Toews; Gary B Huffnagle
Journal:  Infect Immun       Date:  2012-01-17       Impact factor: 3.441

6.  The adaptor protein CIKS/Act1 is essential for IL-25-mediated allergic airway inflammation.

Authors:  Estefania Claudio; Søren Ulrik Sønder; Sun Saret; Gabrielle Carvalho; Thirumalai R Ramalingam; Thomas A Wynn; Alain Chariot; Antonio Garcia-Perganeda; Antonio Leonardi; Andrea Paun; Amy Chen; Nina Y Ren; Hongshan Wang; Ulrich Siebenlist
Journal:  J Immunol       Date:  2009-02-01       Impact factor: 5.422

Review 7.  New immune pathways from chronic post-viral lung disease.

Authors:  Loralyn A Benoit; Michael J Holtzman
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

8.  New drugs targeting Th2 lymphocytes in asthma.

Authors:  Gaetano Caramori; David Groneberg; Kazuhiro Ito; Paolo Casolari; Ian M Adcock; Alberto Papi
Journal:  J Occup Med Toxicol       Date:  2008-02-27       Impact factor: 2.646

9.  Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice.

Authors:  Juliet A Emamaullee; Joy Davis; Shaheed Merani; Christian Toso; John F Elliott; Aducio Thiesen; A M James Shapiro
Journal:  Diabetes       Date:  2009-03-16       Impact factor: 9.461

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.